- Home
- FLYX vs HRTX Comparison
FLYX vs HRTX Comparison
Compare FLYX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- HRTX
- Stock Information
- Founded
- FLYX 2015
- HRTX 1983
- Country
- FLYX United States
- HRTX United States
- Employees
- FLYX N/A
- HRTX N/A
- Industry
- FLYX Blank Checks
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- FLYX Finance
- HRTX Health Care
- Exchange
- FLYX Nasdaq
- HRTX Nasdaq
- Market Cap
- FLYX 175.8M
- HRTX 180.5M
- IPO Year
- FLYX N/A
- HRTX 1987
- Fundamental
- Price
- FLYX $2.25
- HRTX $1.16
- Analyst Decision
- FLYX Hold
- HRTX Strong Buy
- Analyst Count
- FLYX 1
- HRTX 3
- Target Price
- FLYX N/A
- HRTX $5.67
- AVG Volume (30 Days)
- FLYX 21.9K
- HRTX 2.0M
- Earning Date
- FLYX 01-01-0001
- HRTX 11-12-2024
- Dividend Yield
- FLYX N/A
- HRTX N/A
- EPS Growth
- FLYX N/A
- HRTX N/A
- EPS
- FLYX N/A
- HRTX N/A
- Revenue
- FLYX $311,873,000.00
- HRTX $137,737,000.00
- Revenue This Year
- FLYX $15.91
- HRTX $19.15
- Revenue Next Year
- FLYX $39.64
- HRTX $21.29
- P/E Ratio
- FLYX N/A
- HRTX N/A
- Revenue Growth
- FLYX N/A
- HRTX 12.13
- 52 Week Low
- FLYX $1.79
- HRTX $1.04
- 52 Week High
- FLYX $24.21
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- FLYX 45.55
- HRTX 33.38
- Support Level
- FLYX $2.05
- HRTX $1.07
- Resistance Level
- FLYX $2.28
- HRTX $1.17
- Average True Range (ATR)
- FLYX 0.18
- HRTX 0.13
- MACD
- FLYX 0.04
- HRTX -0.01
- Stochastic Oscillator
- FLYX 76.90
- HRTX 13.95
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.